TABLE 3.

Associations between NAFLD status and serum ferritin (ng/ml) in adults aged 18–34 years

	Model 1:β (95% CI), p	Model 2:β (95% CI), p	Model 3:β (95% CI), p
Non‐NAFLD	Reference	Reference	Reference
NAFLD	52.74 (37.76, 67.73), <0.0001	48.52 (33.46,63.58), <0.0001	25.37 (9.17, 41.56), 0.0022
Females
Non‐NAFLD	Reference	Reference	Reference
NAFLD	22.84 (11.50, 34.18) <0.0001	23.33 (11.84,34.81), <0.0001	20.72 (7.45, 33.99) 0.0024
Males
Non‐NAFLD	Reference	Reference	Reference
NAFLD	74.41 (48.33,100.48), <0.0001	63.47 (37.20,89.74), <0.0001	18.85 (−9.41, 47.12), 0.1919

Model 1: no covariates were adjusted. Model 2: age, gender, race were adjusted. Model 3: age, gender (not adjusted for in the subgroup analyses), race, BMI, diabetes, waist circumference, HDL‐cholesterol, glycohemoglobin, AST, ALT, GGT, serum albumin, serum creatinine, and uric acid were adjusted.

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; GGT, gamma glutamyl transpeptidase; HDL, high density lipoprotein; NAFLD, non‐alcoholic fatty liver disease.